Ticker XFOR – Arsanis – sales, description, marketcap – Tickerday.com

XFOR

Arsanis

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 107.73M; Volume: 175.50K; AvgVol 3m: 95.34K; Beta: –;

Cost estimate:

P/E: –; EPS: -3.18; EPS growth quarter/prev quarter: 25.60%;

EPS growth this year: 74.30%; EPS growth past 5 years: ;

EPS ttm: -3.19;

P/S: 38.20; P/B: 1.33; P/Cashflow: 1.11; P/FCF: ;

Sales: 3.00M; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -38.70%; ROE – return on equity: -50.80%; LT Debt/Equity: 0.24; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 2.30%; Insider Transactions:-14.43%;

Institutional Ownership: 69.80%; Institutional Transactions: -0.87%;

Data update: 07/10/2020.